These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 27231279)

  • 1. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
    J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.
    Maisetta G; Grassi L; Esin S; Serra I; Scorciapino MA; Rinaldi AC; Batoni G
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926942
    [No Abstract]   [Full Text] [Related]  

  • 3. Dispersal of Epithelium-Associated Pseudomonas aeruginosa Biofilms.
    Zemke AC; D'Amico EJ; Snell EC; Torres AM; Kasturiarachi N; Bomberger JM
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669459
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms.
    Beaudoin T; Stone TA; Glibowicka M; Adams C; Yau Y; Ahmadi S; Bear CE; Grasemann H; Waters V; Deber CM
    Sci Rep; 2018 Oct; 8(1):14728. PubMed ID: 30283025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
    Chen C; Deslouches B; Montelaro RC; Di YP
    Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
    Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
    BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.
    Anderson GG; Moreau-Marquis S; Stanton BA; O'Toole GA
    Infect Immun; 2008 Apr; 76(4):1423-33. PubMed ID: 18212077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
    Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
    J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium nitrite blocks the activity of aminoglycosides against Pseudomonas aeruginosa biofilms.
    Zemke AC; Gladwin MT; Bomberger JM
    Antimicrob Agents Chemother; 2015; 59(6):3329-34. PubMed ID: 25801569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
    Deslouches B; Islam K; Craigo JK; Paranjape SM; Montelaro RC; Mietzner TA
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3208-16. PubMed ID: 16048927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antibiofilm activity of the synthetic antimicrobial peptide WLBU2 against multiple drug resistant Pseudomonas aeruginosa strains.
    Masihzadeh S; Amin M; Farshadzadeh Z
    BMC Microbiol; 2023 May; 23(1):131. PubMed ID: 37183241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S; Karaaslan E
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
    Moreau-Marquis S; Coutermarsh B; Stanton BA
    J Antimicrob Chemother; 2015 Jan; 70(1):160-6. PubMed ID: 25213272
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa.
    Twomey KB; O'Connell OJ; McCarthy Y; Dow JM; O'Toole GA; Plant BJ; Ryan RP
    ISME J; 2012 May; 6(5):939-50. PubMed ID: 22134647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.
    Moreau-Marquis S; Bomberger JM; Anderson GG; Swiatecka-Urban A; Ye S; O'Toole GA; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L25-37. PubMed ID: 18359885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
    Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
    Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.